George Hill
Stock Analyst at Deutsche Bank
(2.81)
# 1,322
Out of 5,182 analysts
194
Total ratings
51.24%
Success rate
4.29%
Average return
Main Sectors:
Stocks Rated by George Hill
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HQY HealthEquity | Maintains: Buy | $120 → $128 | $81.18 | +57.67% | 19 | Mar 19, 2026 | |
| WAY Waystar Holding | Maintains: Buy | $42 → $37 | $25.23 | +46.65% | 3 | Mar 12, 2026 | |
| TDOC Teladoc Health | Upgrades: Buy | $11 | $6.00 | +83.33% | 19 | Mar 10, 2026 | |
| HIMS Hims & Hers Health | Maintains: Hold | $25 → $28 | $27.91 | +0.32% | 5 | Mar 10, 2026 | |
| ELV Elevance Health | Downgrades: Hold | $332 → $320 | $362.74 | -11.78% | 3 | Dec 19, 2025 | |
| HUM Humana | Maintains: Hold | $250 → $231 | $229.72 | +0.56% | 12 | Nov 7, 2025 | |
| MCK McKesson | Maintains: Buy | $775 → $856 | $835.00 | +2.51% | 8 | Sep 24, 2025 | |
| UNH UnitedHealth Group | Maintains: Buy | $521 → $362 | $366.77 | -1.30% | 22 | May 14, 2025 | |
| CVS CVS Health | Maintains: Buy | $66 → $70 | $80.98 | -13.56% | 7 | Feb 14, 2025 | |
| AGL agilon health | Maintains: Hold | $100 → $50 | $27.90 | +79.21% | 16 | Nov 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $398 → $394 | $284.92 | +38.28% | 10 | Nov 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $119 → $124 | $205.61 | -39.69% | 12 | Nov 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $5 → $2 | $1.90 | +5.26% | 14 | Aug 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $7 → $5 | $1.01 | +395.05% | 4 | Aug 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $82 → $87 | $49.57 | +75.51% | 10 | Aug 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $354 → $353 | $185.46 | +90.34% | 9 | Jul 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $461 → $471 | $229.56 | +105.18% | 2 | Sep 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $6 → $8 | $2.32 | +244.83% | 5 | Aug 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $255 → $250 | $158.98 | +57.25% | 4 | Mar 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $287 → $235 | $102.49 | +129.29% | 5 | Feb 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $250 → $334 | $166.79 | +100.25% | 5 | Feb 18, 2021 |
HealthEquity
Mar 19, 2026
Maintains: Buy
Price Target: $120 → $128
Current: $81.18
Upside: +57.67%
Waystar Holding
Mar 12, 2026
Maintains: Buy
Price Target: $42 → $37
Current: $25.23
Upside: +46.65%
Teladoc Health
Mar 10, 2026
Upgrades: Buy
Price Target: $11
Current: $6.00
Upside: +83.33%
Hims & Hers Health
Mar 10, 2026
Maintains: Hold
Price Target: $25 → $28
Current: $27.91
Upside: +0.32%
Elevance Health
Dec 19, 2025
Downgrades: Hold
Price Target: $332 → $320
Current: $362.74
Upside: -11.78%
Humana
Nov 7, 2025
Maintains: Hold
Price Target: $250 → $231
Current: $229.72
Upside: +0.56%
McKesson
Sep 24, 2025
Maintains: Buy
Price Target: $775 → $856
Current: $835.00
Upside: +2.51%
UnitedHealth Group
May 14, 2025
Maintains: Buy
Price Target: $521 → $362
Current: $366.77
Upside: -1.30%
CVS Health
Feb 14, 2025
Maintains: Buy
Price Target: $66 → $70
Current: $80.98
Upside: -13.56%
agilon health
Nov 8, 2024
Maintains: Hold
Price Target: $100 → $50
Current: $27.90
Upside: +79.21%
Nov 4, 2024
Maintains: Buy
Price Target: $398 → $394
Current: $284.92
Upside: +38.28%
Nov 4, 2024
Maintains: Hold
Price Target: $119 → $124
Current: $205.61
Upside: -39.69%
Aug 14, 2024
Maintains: Hold
Price Target: $5 → $2
Current: $1.90
Upside: +5.26%
Aug 9, 2024
Maintains: Hold
Price Target: $7 → $5
Current: $1.01
Upside: +395.05%
Aug 2, 2024
Maintains: Hold
Price Target: $82 → $87
Current: $49.57
Upside: +75.51%
Jul 29, 2024
Maintains: Hold
Price Target: $354 → $353
Current: $185.46
Upside: +90.34%
Sep 5, 2023
Maintains: Buy
Price Target: $461 → $471
Current: $229.56
Upside: +105.18%
Aug 10, 2023
Maintains: Hold
Price Target: $6 → $8
Current: $2.32
Upside: +244.83%
Mar 23, 2022
Maintains: Buy
Price Target: $255 → $250
Current: $158.98
Upside: +57.25%
Feb 25, 2022
Maintains: Hold
Price Target: $287 → $235
Current: $102.49
Upside: +129.29%
Feb 18, 2021
Maintains: Buy
Price Target: $250 → $334
Current: $166.79
Upside: +100.25%